PRISM BioLab Co.,LTD (TYO:206A)
Japan flag Japan · Delayed Price · Currency is JPY
83.00
-1.00 (-1.19%)
Nov 18, 2026, 11:24 AM JST

PRISM BioLab Co.,LTD Income Statement

Millions JPY. Fiscal year is Oct - Sep.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
518677.33305.62112.93554
Revenue Growth
-23.52%121.63%170.64%-79.62%-
Cost of Revenue
362407.57145.0832.6219
Gross Profit
156269.76160.5480.31535
Selling, General & Admin
1,2751,044942.93238.08468
Research & Development
---338.73-
Operating Expenses
1,2751,044942.93577.17468
Operating Income
-1,119-774.45-782.39-496.8767
Interest & Investment Income
135.30.360.02-
Currency Exchange Gain (Loss)
1721.5-15.54-0.7713
Other Non Operating Income (Expenses)
--0.65-34.10.07-3
EBT Excluding Unusual Items
-1,089-748.3-831.67-497.5577
Gain (Loss) on Sale of Assets
-92-0.25-0-4
Asset Writedown
--82.98-216.78-28.15-
Pretax Income
-1,181-831.28-1,048-525.773
Income Tax Expense
22.421.311.211
Net Income
-1,183-833.7-1,050-526.9172
Net Income to Common
-1,183-833.7-1,050-526.9172
Net Income Growth
-----
Shares Outstanding (Basic)
3737312827
Shares Outstanding (Diluted)
3737312827
Shares Change
1.14%16.70%13.40%0.94%-
EPS (Basic)
-32.02-22.82-33.53-19.092.63
EPS (Diluted)
-32.02-22.82-33.53-19.092.63
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Free Cash Flow
--1,533-55.64-548.4-
Free Cash Flow Per Share
--41.97-1.78-19.87-
Gross Margin
30.12%39.83%52.53%71.11%96.57%
Operating Margin
-216.02%-114.34%-256.00%-439.99%12.09%
Profit Margin
-228.38%-123.09%-343.41%-466.60%13.00%
Free Cash Flow Margin
--226.34%-18.21%-485.63%-
EBITDA
---773.65-488.13-
EBITDA Margin
---253.14%--
D&A For EBITDA
--8.748.74-
EBIT
-1,119-774.45-782.39-496.8767
EBIT Margin
-216.02%-114.34%-256.00%-12.09%
Effective Tax Rate
----1.37%